Your hair cycle changed 3 months before you saw it

HAIR SHEDDING

6 min read

You found it on the pillow. Then in the shower drain. Then wrapped around your fingers when you ran your hand through. It was always some. Now it is more. Every hair on your head is on a timer. The growth phase lasts two to six years. The resting phase lasts two to three months. At the end of the resting phase, the hair falls. What you see on the pillow today was decided by the follicle three months ago.

You are not imagining the increase. The ratio of growing hairs to resting hairs shifted, and the hair that falls today is the evidence of a change that happened months before you noticed.

The hair cycle has two phases that matter here. The growth phase, called anagen, is when the follicle actively produces hair. The resting phase, called telogen, is when the follicle releases the hair and pauses before starting again. In a healthy scalp, roughly 85 to 90 percent of follicles are in anagen at any given time. In postmenopausal women, a 2025 review in Maturitas confirmed that the ratio shifts: more follicles enter telogen, and the growth phase shortens.

Estrogen promotes the growth phase through a signaling pathway that keeps the follicle actively producing hair. When estrogen declines, that signal weakens, anagen shortens, and more follicles enter the resting phase at once. Every 50 percent reduction in anagen duration corresponds to a doubling of follicles in telogen. The math is direct: shorter growth means more shedding.

Consultations for diffuse hair loss peak between ages 50 and 60, coinciding with the transition. The prevalence is high enough that a dermatologist seeing a woman in this age group will ask about shedding as a matter of course. Erratic estrogen levels during perimenopause can also trigger episodes of chronic shedding even when levels are still within the normal range, because the follicle responds to fluctuation itself.

WHAT IT DOES NOT ESTABLISH

Whether the shedding in any individual is driven primarily by hormonal change, iron levels, thyroid function, stress, or a combination. Low serum ferritin is significantly associated with increased shedding in women. The hormonal connection is well supported by the research, but other factors can produce the same pattern independently, and several can operate at once.

THE ANAGEN-TO-TELOGEN RATIO

At any moment, each follicle on the scalp is either growing a hair (anagen) or resting between cycles (telogen). The ratio between the two determines how much hair you have and how much you shed. In a healthy scalp, roughly 85 to 90 percent of follicles are in the growth phase. When that ratio tilts, more hairs reach the end of their resting phase and fall at once. The shedding is diffuse, coming from everywhere rather than one spot.

THE NUMBERS

52%

Of 178 healthy postmenopausal women had visible hair thinning in a cross-sectional study. Consultations for diffuse hair loss peak between ages 50 and 60. Maturitas, 2025.

3 months

The delay between when a follicle enters its resting phase and when the hair falls. What you notice on the pillow now reflects a change that the follicle made a quarter of a year ago.

More than half the women in the study had visible thinning. The three-month delay explains why the shedding seems to come from nowhere: the change happened months before you could see it, and by the time you could, it had already been underway for a full season.

THE STRONGEST EVIDENCE

Topical minoxidil

FDA APPROVED, META-ANALYSIS CONFIRMED

Topical minoxidil is the only FDA-approved approach for female pattern hair loss. A meta-analysis found it effective and safe across concentrations, and effective regardless of age. It works by extending the growth phase of the hair cycle and increasing follicle size. Available over the counter in 2 percent and 5 percent concentrations.

Hair grows slowly. The American Academy of Dermatology says to allow 6 to 12 months of daily use before deciding whether it is working. In the first 2 to 8 weeks, shedding may temporarily increase as follicles shift from resting back into active growth. This is expected and resolves.

“Minoxidil is the most-recommended treatment for FPHL. Products containing either 2% or 5% minoxidil have been approved to treat FPHL.”

AMERICAN ACADEMY OF DERMATOLOGY

WHAT IT IS NOT

Minoxidil does not address the hormonal shift driving the cycle change. It extends anagen through a separate pathway. If you stop using it, regrowth that occurred because of minoxidil will gradually shed. It works best when started early, before significant thinning has progressed.

WHEN TO PAY ATTENTION

Sudden patches of complete hair loss, smooth bare areas rather than overall thinning. This is a different pattern that warrants evaluation by a dermatologist.

Hair loss accompanied by scalp itching, burning, or redness. These can indicate an inflammatory process that responds to specific care and should be seen by a dermatologist.

Hair loss with fatigue, weight changes, or sensitivity to temperature. These can point to thyroid function or iron levels, both of which are testable with a simple blood draw.

THIS WEEK

This morning, run your fingers along your part line from the forehead toward the crown. Notice the width and whether the scalp is more visible than it was a year ago. This is the same observation a dermatologist begins with.

For the next week, notice where the hair accumulates: pillow, shower drain, brush. Whether the shedding is diffuse or concentrated near the part tells a dermatologist which pattern is involved.

If shedding has been persistent for more than three months, or if the part has visibly widened, bring these observations to a dermatologist. The AAD recommends starting early because the available approaches work best before significant thinning has progressed.

The part line check takes ten seconds. Run your fingers through, feel the width, notice what you see. That observation, made once this morning, is enough to know whether it is worth bringing to a dermatologist. The hair that falls today started its resting phase months ago. What you do next starts now.

ONE TAP, NO FORM

Where did you notice it first?

Tapping opens a pre-written reply. Nothing is public, nothing goes to a list. What most readers tap decides what gets explained next.

The shower drain filled up faster

My ponytail felt thinner in my hand

I see more scalp than I used to

It started when my periods became irregular

Or write in your own words. Every reply is read.

Read recent issues

EVERY SOURCE READ FOR THIS ISSUE

Six sources: one comprehensive review on hair and the menopausal transition, one prevalence study in postmenopausal women, one hair cycle and clock gene analysis, one serum ferritin and shedding study, one minoxidil meta-analysis summary, and one professional body guideline.

1	Menopause and hair loss in women: exploring the hormonal transition Comprehensive review, Maturitas, 2025

2	Fluctuating estrogen levels during menopausal transition may influence clock genes and trigger chronic telogen effluvium Hair cycle analysis, Dermatology Online Journal, 2014

3	Assessment of serum ferritin levels in female patients with telogen effluvium Case-control study, 50 women with TE vs 50 controls, Cureus, 2025

4	Thinning hair and hair loss: could it be female pattern hair loss? Patient guidance, American Academy of Dermatology

5	Prevalence of female pattern hair loss in postmenopausal women: a cross-sectional study Cross-sectional study, 178 women, Chaikittisilpa et al., Menopause, 2022

6	Male and female pattern hair loss: a guide to treatment Expert summary citing meta-analysis, Cleveland Clinic ConsultQD, 2026

Read more from The Cortisol Effect